Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.002 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.002 |
mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.24 | 0.003 |
mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.003 |